25+ years of experience
She helps clients understand how payers see products, and how to calibrate pharmaceutical strategies.
Her team covers a wide range of pharma strategy topics, including pricing and reimbursement, and healthcare reforms.
She has introduced new disease pricing and reimbursement analysis, giving clients timely insights into key drivers of reimbursement and health technology assessment decisions in major markets.
Tijana writes For
By Tijana Ignjatovic 23 Nov 2015
Despite the challenges with the implementation of managed entry agreements, the debate involving these complex market access routes is not abating.
23 Nov 2015